Market Overview

Evofem Biosciences to Report Third Quarter 2019 Results and Provide Corporate Update on November 7, 2019

Share:

SAN DIEGO, Oct. 24, 2019 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ:EVFM) will hold a webcast and conference call to discuss the Company's financial results and business highlights for the third quarter ended September 30, 2019.

(PRNewsfoto/Evofem Biosciences, Inc.)

Date

Thursday November 7, 2019

Time

11:00 a.m. EST (8:00 a.m. PST)

Dial-in numbers

(866) 503-5561 (U.S. toll-free) or (253) 336-2965

Passcode

3857878

Webcast (live and archived)

www.evofem.com under "Investors" or click here

The live webcast and related slide presentation can be accessed on the Company's Investor page at https://evofem.investorroom.com/events. Please connect to the Company's website at least 15 minutes prior to the start of the call to download any software that may be required. If participating by phone, please dial in approximately 10 minutes prior to the start of the call.

A telephone replay will be available approximately two hours after the call through Tuesday, November 12, 2019 at (855) 859-2056 (U.S.) or (404) 537-3406 (International), access code 3857878. The webcast will be archived at https://evofem.investorroom.com/events

About Evofem Biosciences
Evofem Biosciences, Inc. is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. Evofem Biosciences aims to advance the lives of women by developing novel solutions, such as woman-controlled contraception and potential protection from certain sexually transmitted infections. The Company is leveraging its proprietary Multipurpose Vaginal pH Regulator (MVP-R™) platform to develop Amphora® (L-lactic acid, citric acid and potassium bitartrate) for hormone-free birth control and prevention of chlamydia. For more information, please visit www.evofem.com.

Amphora® is a registered trademark and MVP-R™ is a trademark of Evofem Biosciences, Inc.

Investor Contact
Amy Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
M: (917) 673-5775

Media Contact
Cara Miller
Evofem Biosciences, Inc.
cmiller@evofem.com
O: (858) 550-1900 x272

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/evofem-biosciences-to-report-third-quarter-2019-results-and-provide-corporate-update-on-november-7-2019-300944544.html

SOURCE Evofem Biosciences, Inc.

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com